AI Drug Firm Recursion Wants to Be the Amazon Prime of Pharma

Published on March 1, 2025

AI drug developer Recursion Pharmaceuticals Inc. is considering an Amazon Prime-style subscription model for selling its pipeline of medicines.

Continue reading on website
Other news

Emerging Markets Rattled as Trump Dials Up Tariff Threats

March 1, 2025
Emerging markets were swept up in the global equities storm Friday, with Asian stocks taking the heaviest beating after President Donald Trump’s latest tariff threats.

Tencent Fires Up AI Race With Model It Says Outdoes DeepSeek

March 1, 2025
Tencent Holdings Ltd. became the latest tech company to unveil or enhance an AI model intended to eclipse DeepSeek, joining a spate of rollouts since the startup’s emergence energized the US-China technology race.